201 related articles for article (PubMed ID: 9420256)
1. 71-kilodalton heat shock cognate protein acts as a cellular receptor for syncytium formation induced by human T-cell lymphotropic virus type 1.
Sagara Y; Ishida C; Inoue Y; Shiraki H; Maeda Y
J Virol; 1998 Jan; 72(1):535-41. PubMed ID: 9420256
[TBL] [Abstract][Full Text] [Related]
2. Phosphatidylglycerol participates in syncytium formation induced by HTLV type 1-bearing cells.
Sagara Y; Inoue Y; Kojima E; Ishida C; Shiraki H; Maeda Y
AIDS Res Hum Retroviruses; 2001 Jan; 17(2):125-35. PubMed ID: 11177392
[TBL] [Abstract][Full Text] [Related]
3. Heat shock cognate protein 70 is a cell fusion-enhancing factor but not an entry factor for human T-cell lymphotropic virus type I.
Fang D; Haraguchi Y; Jinno A; Soda Y; Shimizu N; Hoshino H
Biochem Biophys Res Commun; 1999 Aug; 261(2):357-63. PubMed ID: 10425190
[TBL] [Abstract][Full Text] [Related]
4. HTLV type 1 envelope glycoprotein gp46 evokes necrosis by binding to receptor complex.
Sagara Y; Inoue Y; Kojima E; Shiraki H; Maeda Y
AIDS Res Hum Retroviruses; 2000 Nov; 16(16):1701-4. PubMed ID: 11080813
[TBL] [Abstract][Full Text] [Related]
5. Trypsin-sensitive and -resistant components in human T-cell membranes required for syncytium formation by human T-cell lymphotropic virus type 1-bearing cells.
Sagara Y; Ishida C; Inoue Y; Shiraki H; Maeda Y
J Virol; 1997 Jan; 71(1):601-7. PubMed ID: 8985389
[TBL] [Abstract][Full Text] [Related]
6. The synthetic peptide P-197 inhibits human T-cell leukemia virus type 1 envelope-mediated syncytium formation by a mechanism that is independent of Hsc70.
Brighty DW; Jassal SR
J Virol; 2001 Nov; 75(21):10472-8. PubMed ID: 11581416
[TBL] [Abstract][Full Text] [Related]
7. Novel biomarker of HTLV-1-associated disease: specific appearance of antibody recognizing the receptor-binding site on HTLV-1 envelope protein.
Sagara Y; Inoue Y; Tsujimura M; Kojima E; Shiraki H; Kashiwagi S
Cancer Sci; 2004 Oct; 95(10):835-9. PubMed ID: 15504252
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of synapse-associated protein Dlg1 reduces syncytium formation induced by human T-cell leukemia virus type 1.
Yoshida S; Higuchi M; Shoji T; Yoshita M; Ishioka K; Takahashi M; Oie M; Tanaka Y; Uchiyama M; Fujii M
Virus Genes; 2008 Aug; 37(1):9-15. PubMed ID: 18461433
[TBL] [Abstract][Full Text] [Related]
9. Syncytium-inhibiting monoclonal antibodies produced against human T-cell lymphotropic virus type 1-infected cells recognize class II major histocompatibility complex molecules and block by protein crowding.
Hildreth JE
J Virol; 1998 Dec; 72(12):9544-52. PubMed ID: 9811687
[TBL] [Abstract][Full Text] [Related]
10. Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.
Palker TJ; Tanner ME; Scearce RM; Streilein RD; Clark ME; Haynes BF
J Immunol; 1989 Feb; 142(3):971-8. PubMed ID: 2563272
[TBL] [Abstract][Full Text] [Related]
11. Identification and mapping of functional domains on human T-cell lymphotropic virus type 1 envelope proteins by using synthetic peptides.
Sagara Y; Inoue Y; Shiraki H; Jinno A; Hoshino H; Maeda Y
J Virol; 1996 Mar; 70(3):1564-9. PubMed ID: 8627675
[TBL] [Abstract][Full Text] [Related]
12. Identification of membrane antigen C33 recognized by monoclonal antibodies inhibitory to human T-cell leukemia virus type 1 (HTLV-1)-induced syncytium formation: altered glycosylation of C33 antigen in HTLV-1-positive T cells.
Fukudome K; Furuse M; Imai T; Nishimura M; Takagi S; Hinuma Y; Yoshie O
J Virol; 1992 Mar; 66(3):1394-401. PubMed ID: 1738199
[TBL] [Abstract][Full Text] [Related]
13. Soluble recombinant HTLV-1 surface glycoprotein competitively inhibits syncytia formation and viral infection of cells.
Jassal SR; Lairmore MD; Leigh-Brown AJ; Brighty DW
Virus Res; 2001 Oct; 78(1-2):17-34. PubMed ID: 11520577
[TBL] [Abstract][Full Text] [Related]
14. Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. A basis for the design of an HTLV-1 peptide vaccine.
Baba E; Nakamura M; Tanaka Y; Kuroki M; Itoyama Y; Nakano S; Niho Y
J Immunol; 1993 Jul; 151(2):1013-24. PubMed ID: 7687611
[TBL] [Abstract][Full Text] [Related]
15. Identification of new epitopes recognized by human monoclonal antibodies with neutralizing and antibody-dependent cellular cytotoxicity activities specific for human T cell leukemia virus type 1.
Kuroki M; Nakamura M; Itoyama Y; Tanaka Y; Shiraki H; Baba E; Esaki T; Tatsumoto T; Nagafuchi S; Nakano S
J Immunol; 1992 Aug; 149(3):940-8. PubMed ID: 1378869
[TBL] [Abstract][Full Text] [Related]
16. Neutralizing human monoclonal antibodies to conformational epitopes of human T-cell lymphotropic virus type 1 and 2 gp46.
Hadlock KG; Rowe J; Perkins S; Bradshaw P; Song GY; Cheng C; Yang J; Gascon R; Halmos J; Rehman SM; McGrath MS; Foung SK
J Virol; 1997 Aug; 71(8):5828-40. PubMed ID: 9223472
[TBL] [Abstract][Full Text] [Related]
17. Stability of the HTLV-1 glycoprotein 46 (gp46) gene in an endemic region of the Brazilian Amazon and the presence of a significant mutation (N93D) in symptomatic patients.
Socorro de Almeida Viana MND; Santos Nobre AF; Costa E; Silva IC; Pinheiro BT; Pereira CCC; de Souza Canto Ferreira L; de Almeida DS; de Araújo MWL; da Silva Borges M; da Costa CA; Ishikawa EAY; Ferrari SF; Silva de Sousa M
Virol J; 2018 May; 15(1):80. PubMed ID: 29716616
[TBL] [Abstract][Full Text] [Related]
18. Epitope mapping of human monoclonal antibodies recognizing conformational epitopes within HTLV type 1 gp46, employing HTLV type 1/2 envelope chimeras.
Hadlock KG; Yang Q; Rowe J; Foung SK
AIDS Res Hum Retroviruses; 2002 Jan; 18(1):57-70. PubMed ID: 11804557
[TBL] [Abstract][Full Text] [Related]
19. Human T-cell lymphotropic virus type 1 (HTLV-1)-induced syncytium formation mediated by vascular cell adhesion molecule-1: evidence for involvement of cell adhesion molecules in HTLV-1 biology.
Hildreth JE; Subramanium A; Hampton RA
J Virol; 1997 Feb; 71(2):1173-80. PubMed ID: 8995639
[TBL] [Abstract][Full Text] [Related]
20. Arsenic trioxide induces down-regulation of gp46 via protein oxidation: proteomics analysis of oxidative modified proteins in As2O3-treated HTLV-1-infected cells.
Nabeshi H; Yoshikawa T; Kamada H; Shibata H; Sugita T; Abe Y; Nagano K; Nomura T; Minowa K; Tsunoda S; Tsutsumi Y
Pharmazie; 2010 Sep; 65(9):702-7. PubMed ID: 21038850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
